Anti-tumor effect associated with down-regulation of MHC class 1 antigen after co-transfection of GM-CSF and IFN-γ genes in CT26 tumor cells

Anticancer Research

Volumn 21, Issue 6 A, 2001, Pages 4031-4039

  Yoon, Seong Jun ^a   Lee, June Chul ^a   Kang, Jung Ok ^a   Lee, Sang Goo ^a   Heo, Dae Seog ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Cytokine; Gene therapy; MHC; Neoplasms; Rodent

Indexed keywords

BETA 2 MICROGLOBULIN; GENE PRODUCT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RECOMBINANT GAMMA INTERFERON; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL POPULATION; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BETA 2-MICROGLOBULIN; COLONIC NEOPLASMS; DOWN-REGULATION; FEMALE; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERFERON-GAMMA, RECOMBINANT; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED BALB C; RETROVIRIDAE; TRANSFECTION;

EID: 0035570255     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Structure of the human class I histocompatibility antigen, HLA-A2
2. Antigen recognition by class I restricted T lymphocytes
3. Mechanisms of MHC class I-restricted antigen processing
4. Degradation of cell proteins and the generation of MHC class I-presented peptides
5. Getting the inside out: The transporter associated with antigen processing (TAP) and the presentation of viral protein
6. Antigen-processing machinery breakdown and tumor growth
7. Identification of human cancers deficient in antigen processing
8. Perspectives on the role of MHC antigens in normal and malignant cell development
9. Modulation of MHC antigen expression by viruses and oncogenes
10. Analysis of the MHC class I antigen presentation machinery in normal and malignant renal cells: Evidence for deficiencies associated with transformation and progression
11. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinoma
12. Loss of interferon-gamma inducibility of TAP-1 and LMP2 in a renal cell carcinoma cell line
13. Immunotherapy of a murine tumor with interleukin-2: Increased sensitivity after MHC class I gene transfection
14. Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans
15. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans
16. Cellular immune response to human renal-cell carcinomas: Definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones
17. 2-microglobulin gene in cancer patients
18. Synergistic anti-tumor effect with coexpression of GM-CSF and IFN-γ in tumors
19. Tumor induction relationships in development of transplantable cancers of the colon in mice for chenotherapy assay, with a note on carcinogen structure
20. d histo-compatibility antigen
21. Polymorphism in the mouse TAP-1 gene
22. Structure of wild-type and mutant mouse beta 2-microglobulin genes
23. The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol
24. Cleavages of structural proteins during the assembly of the head of bacteriophage T4
25. + T cells
26. Molecular charaterization of antigen-processing function in nasopharyngeal carcinoma (NPC): Evidence for efficient presentation of epstein-barr virus cytotoxic T-cell epitopes by NPC cells
27. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer
28. Suppression of MHC class I RNA in highly oncogenic cells occurs at the level of transcription initiation
29. Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis
30. + cells
31. Rejection of BL 6 melanoma induced by the expression of a transfected MHC class I gene
32. b gene
33. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAPI alone in antigen processing
34. Interferon-γ rapidly increases peptide transporter (TAP) subunit expression and peptide transport capacity in endothelial cells
35. Synergistic induction of the Tap-1 gene by IFN-gamma and lipopolysaccharide in macrophages is regulated by STATI
36. 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2)